| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/26/2006 | CN1762488A Externally applied medicinal composition of human cell fibronectin and preparation method thereof |
| 04/26/2006 | CN1762487A IL-2 precursor liposome and its preparation method |
| 04/26/2006 | CN1762486A Use of cerebrosid-kinin in preparation of medicine for preventing and treating peripheral nerve disease |
| 04/26/2006 | CN1762485A Aglycin group and its application in preparation of medicine or food for treating diabetes |
| 04/26/2006 | CN1762416A Rehabilitation lyophilized powder injection and its preparation method |
| 04/26/2006 | CN1762383A Preparation process of hepatic cell growth promotion protein and its injection preparation method |
| 04/26/2006 | CN1762381A Ophthalmic compositions containing galactomannan polymers and borate |
| 04/26/2006 | CN1762337A Eye wrinkle-removing film patch |
| 04/26/2006 | CN1762325A Toxic and side effect-free externally-applied health-care cream for removing wrinkle, caring skin and keeping fitness |
| 04/26/2006 | CN1253572C Isolated peptides which bind to HLA-C molecules and uses thereof |
| 04/26/2006 | CN1253569C Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use |
| 04/26/2006 | CN1253565C Instant enzymes formulations used for animal feed |
| 04/26/2006 | CN1253551C Genetically modified tumor-targeted bacteria with reduced virulence |
| 04/26/2006 | CN1253528C Desiccation compositions containing hydrophobic amino acid |
| 04/26/2006 | CN1253473C Medicinal collagen material and its making process |
| 04/26/2006 | CN1253472C Polyglycol-human growth hormone conjugate and its preparation process and medicinal use |
| 04/26/2006 | CN1253471C Type CC chemokine-like protein |
| 04/26/2006 | CN1253470C Treatment of inflammatory disease |
| 04/26/2006 | CN1253469C Antigenic determinant polypeptide of human tumor-testis antigen HCA587 and use thereof |
| 04/26/2006 | CN1253468C Estrogen-growth hormone release peptide possessing the function of resisting osteoporosis |
| 04/26/2006 | CN1253442C Novel thiazine or pyrazine derivatives |
| 04/26/2006 | CN1253204C Biological process for the production of a food product comprising heme-iron and food product obtained with said process |
| 04/26/2006 | CN1253147C Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof |
| 04/25/2006 | USRE39078 Recombinant adenoviruses for gene therapy in cancers |
| 04/25/2006 | US7035856 System and method for tracking and routing shipped items |
| 04/25/2006 | US7034943 Gas sensors |
| 04/25/2006 | US7034141 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 04/25/2006 | US7034132 Nucleic acid sequences that encode G- coupled protein-receptor related polypeptides; diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving these human nucleic acids and proteins |
| 04/25/2006 | US7034127 Hydrophilic biopolymer-drug conjugates, their preparation and use |
| 04/25/2006 | US7034126 Lactoferrin in the treatment of diabetes mellitus |
| 04/25/2006 | US7034118 Isolation nucleic acids; genetic engineering |
| 04/25/2006 | US7034115 Transposase and method of gene modification |
| 04/25/2006 | US7034113 Bacteriocin-metal complexes in the detection of pathogens and other biological analytes |
| 04/25/2006 | US7034112 Nucleotide sequences coding enzymatic polypeptide for use in the treatment and prevention of nervous system disorders |
| 04/25/2006 | US7034111 17867, a novel human aminopeptidase |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034108 Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereof |
| 04/25/2006 | US7034105 Endothelial growth factors (Flt4); glycoproteins; tyrosine kinases; immunoglobulins |
| 04/25/2006 | US7034050 Animal growth regulators |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034009 Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R) |
| 04/25/2006 | US7034008 Unitary catheter drug delivery device for delivering polynucleotide to cardiac tissue of the patient, capable of modulating an electrical property of the heart, and designed to suppress K channels; electrode to detect position of the device within the patient |
| 04/25/2006 | US7034006 Use of lipid conjugates in the treatment of disease |
| 04/25/2006 | US7034004 Peptide for controlling appetite |
| 04/25/2006 | US7034003 Somatostatin and somatostatin agonists for decreasing body weight |
| 04/25/2006 | US7034002 Angiotensin converting enzyme inhibitor |
| 04/25/2006 | US7034001 Methods of therapy with thrombin derived peptides |
| 04/25/2006 | US7034000 Peptides derived from the human amyloid precursor protein |
| 04/25/2006 | US7033999 Muscle relaxants; anticoagulants; cardiovascular disorders |
| 04/25/2006 | US7033998 Alcohol-free transdermal insulin composition and processes for manufacture and use thereof |
| 04/25/2006 | US7033997 Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections |
| 04/25/2006 | US7033996 Hypercalcemia therapy; administering a protein which controls hydrolasase enzyme |
| 04/25/2006 | US7033995 Production of radial glial cells |
| 04/25/2006 | US7033994 Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy |
| 04/25/2006 | US7033993 Polypeptide for use in biological pest control |
| 04/25/2006 | US7033992 Formulations for IL-11 |
| 04/25/2006 | US7033991 Enzyme inhibitor; administering oligopeptides; efficient transportation of cell membrane |
| 04/25/2006 | US7033830 Antisense modulation of MyD88 expression |
| 04/25/2006 | US7033828 Nucleic acid encoding gamma retinoic acid receptor fusion protein |
| 04/25/2006 | US7033825 Nucleotide sequences coding polypeptide for use in the treatment of nephritis, cancer and kidney disorders |
| 04/25/2006 | US7033812 β-secretase and modulation of β-secretase activity |
| 04/25/2006 | US7033809 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/25/2006 | US7033805 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase. |
| 04/25/2006 | US7033799 Haemophilus adherence and penetration proteins |
| 04/25/2006 | US7033796 cloned from cDNA library of human liver carcinoma cell line using PCR amplification; host cells |
| 04/25/2006 | US7033794 Basolateral sorting signal and inhibitors thereof |
| 04/25/2006 | US7033793 Genes and proteins can be used in making transgenic animals and in assays designed to determine the likelihood of an individual developing cardiomyopathy |
| 04/25/2006 | US7033792 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 04/25/2006 | US7033791 Nucleic acid molecules encoding modified factor VIII proteins, expression products, and methods of making the same |
| 04/25/2006 | US7033788 Saxatilin isolated via gel fitration of venom from vipers, then performing high performance liquid chromatography; for use as anti-platelet aggregation agents and antitumor agents |
| 04/25/2006 | US7033787 For use in therapy |
| 04/25/2006 | US7033777 Contacting a sample and a substrate-formulation containing a chitinase substrate to cause measurable change in a property when chitinase is present in the sample, determining the magnitude of the change in property by colorimetry fluorometry |
| 04/25/2006 | US7033776 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 04/25/2006 | US7033771 contacting composition of insulin-responsive aminopeptidase (IRAP) and human trancytosis-associated protein (TAP) with a test compound and determining binding; glucose transporter proteins; vesicle transport proteins |
| 04/25/2006 | US7033770 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 04/25/2006 | US7033755 Diagnostics and therapeutics for glaucoma |
| 04/25/2006 | US7033752 Spinal muscular atrophy diagnostic methods |
| 04/25/2006 | US7033750 Recombinant P53 adenovirus methods and compositions |
| 04/25/2006 | US7033615 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues |
| 04/25/2006 | US7033613 Serine substituted gold inserted apoferritin; transport proteins; for use in producing semiconductors |
| 04/25/2006 | US7033611 Matrix protein compositions for guided connective tissue growth |
| 04/25/2006 | US7033610 Basic cell growth stimulating factors from a mammal milk product having basic to neutral isoelectric points, enriched with proliferation stimulant of rat myoblasts; wound healing agents for gastrointestinal injuries and skin |
| 04/25/2006 | US7033609 Microparticle preparation |
| 04/25/2006 | US7033605 performing an ocular transplant procedure; implanting in the eye a biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer. |
| 04/25/2006 | US7033604 Composition for topical administration |
| 04/25/2006 | US7033597 Intracellular delivery of biological effectors |
| 04/25/2006 | US7033594 Method of treatment using ligand-immunogen conjugates |
| 04/25/2006 | US7033591 use of a membrane fraction of gram-negative bacteria such as Klebsiella pnemoniae comprising proteoglycans in combination with anticancer treatment for immunostimulant and/or inducing an antitumor immune response in mammals including humans |
| 04/25/2006 | US7033590 Factor IX/factor IXa activating antibodies and antibody derivatives |
| 04/25/2006 | US7033589 γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/25/2006 | US7033588 combination of coenzyme Q and a surfactant can prevent ascites even when administering in a small dose and within a short period of time |
| 04/25/2006 | US7033585 Immunologically privileged cells and uses thereof |
| 04/25/2006 | US7033582 Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| 04/25/2006 | US7033572 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/25/2006 | CA2493827A1 Natural product derivatives as food supplements and pharmaceuticals |
| 04/25/2006 | CA2288429C Pegylation of polypeptides |
| 04/25/2006 | CA2236912C Vectors and methods for gene transfer to cells |
| 04/21/2006 | CA2493831A1 Amino acid esters as nutrient supplements and methods of use |
| 04/21/2006 | CA2493398A1 Nutritional and food supplement preparation comprising creatine and orotic acid complexes, derivatives and analogs |
| 04/20/2006 | WO2006042282A2 Peptide inhibitors against seprase |